Dr. Abidi Pharmaceutical Laboratories (DABID) operating revenue
Sales quantity, amount and rate by product and sale type
Fundamental analysis of DABID on Fundai: DABID Fundamental Analysis, Mehr 1405: Profit Forecast and Valuation
- Ticker
- DABID
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | Unit | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|---|
| Other | million rials | 54,268,369 | 868,395 | 558,972 | 234,517 | 68,072 | - |
| Syrup and suspension | million rials | 4,667,107 | 2,394,524 | 1,974,153 | 2,093,840 | 1,353,938 | - |
| Tablets | million rials | 149,831,254 | 75,468,358 | 48,088,536 | 38,292,918 | 21,629,176 | 11,765,261 |
| Capsules | million rials | 34,547,010 | 17,165,078 | 8,290,745 | 5,928,501 | 4,853,380 | 3,629,312 |
| Total domestic sales | million rials | 243,313,740 | 95,896,355 | 58,912,406 | 46,549,776 | 27,904,566 | 15,925,840 |
| Total | million rials | 243,313,740 | 95,896,355 | 58,912,406 | 46,549,776 | 27,904,566 | 15,925,840 |
| Total export sales | million rials | 0 | 0 | 0 | 0 | 0 | 0 |
Reporting periods
42 periods are on file for this report, from the period ending 1395/03/31 to the period ending 1405/06/31.